Neagoe M
Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir. 1980 Jul-Aug;29(4):259-65.
A total of 12 patients were prophylactically treated with Thio-Tepa, that had presented papillary bladder tumours operated in stages T0, T1 and T2. The treatment consisted in intra-vesical instillations with 50 mg of substance solved in 50 ml of distilled water. The solution was maintained for one hour inside the urinary bladder. The instillations were repeated at 5--7 days intervals for 4 times. The following series of instillations was carried out at 3--4 months intervals by comparing the results with those obtained in a control lot it was noted that 41 percent of the patient did not recidivate over a period of between 13 and 34 months, while recidives, occurred in all the patients in the control lot. On the other hand intra-vesical instillations with Thio-Tepa have retarded in some of the cases the occurrence of tumoral recidives (22 percent of the patients recidivated in the first 6 months, in contrast with the controls in whom recidives occurred in 72 percent in the same time interval). No secondary effects were noted as a result of the endo-vesical instillations with the preparation.
共有12例患有T0、T1和T2期乳头状膀胱肿瘤且已接受手术治疗的患者接受了硫替派预防性治疗。治疗方法是将50毫克药物溶解于50毫升蒸馏水中进行膀胱内灌注。溶液在膀胱内保留1小时。每隔5 - 7天重复灌注1次,共进行4次。接下来每隔3 - 4个月进行一系列灌注,通过与对照组的结果比较发现,41%的患者在13至34个月期间未复发,而对照组所有患者均复发。另一方面,硫替派膀胱内灌注在一些病例中延缓了肿瘤复发的发生(22%的患者在最初6个月复发,相比之下对照组在同一时间间隔内复发率为72%)。未观察到该制剂膀胱内灌注产生的副作用。